NCT01360411

Brief Summary

In this single centre study we study the use of endoscopic ultrasonography (EUS) combined with elastography in order to separate malignant tissue from benign tissue in and adjacent to the upper gastrointestinal tract.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
137

participants targeted

Target at P50-P75 for all trials

Timeline
Completed

Started Jan 2007

Longer than P75 for all trials

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

January 1, 2007

Completed
3.3 years until next milestone

First Submitted

Initial submission to the registry

April 26, 2010

Completed
1.1 years until next milestone

First Posted

Study publicly available on registry

May 25, 2011

Completed
1 year until next milestone

Primary Completion

Last participant's last visit for primary outcome

June 1, 2012

Completed
1 month until next milestone

Study Completion

Last participant's last visit for all outcomes

July 1, 2012

Completed
Last Updated

September 5, 2012

Status Verified

September 1, 2012

Enrollment Period

5.4 years

First QC Date

April 26, 2010

Last Update Submit

September 4, 2012

Conditions

Keywords

elastographystrain ratiopancreasGI wall lesionslymph nodes

Outcome Measures

Primary Outcomes (1)

  • Malignant or benign lesion

    Imaged lesions are sampled, surgically removed or followed up \> 6 months to conclude on their nature. Images are evaluated, measured and categorised shortly after examination and compared to histological, cytological or follow up result. Elastography results do not interfere with surgical or oncological treatment planning in this study.

    Jan 2007 - September 2011 + 6 months( if no tissue sample)(4 years)

Secondary Outcomes (4)

  • Description of lesion elasticity

    2007- September 2011 (4 years)

  • Value of Strain Ratio measurements

    2007 - September 2011 (4 years)

  • Value of colour and pattern category

    2007 - September 2011 (4 years)

  • Value of a Visual Analog Scale for strain image categorisation

    2007 - September 2011 (4 years)

Study Arms (3)

Pancreatic lesions

Any patient with a solid pancreatic lesion of unknown histology may be recruited. Cystic lesions are not included. Elastography findings are classified and compared to cytology or histology if the standard procedures or treatment provide this. In other cases the patients are being followed up conservatively.

Intramural upper GI-lesions

Patients with intramural lesions discovered by endoscopy or other imaging modalities are recruited. Elastography findings are classified and compared to cytology or histology if the standard procedures or treatment provide this. In other cases the patients are being followed up conservatively.

Lymph nodes

Patients with visible mediastinal lymph nodes or retroperitoneal lymph nodes in patients with inflammatory or malignant diseases are recruited. Elastography findings are classified and compared to cytology or histology if the standard procedures or treatment provide this. In other cases the patients are being followed up conservatively.

Eligibility Criteria

Age18 Years - 90 Years
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)
Sampling MethodNon-Probability Sample
Study Population

Adult patients referred to EUS examination or relevant surgery at Haukeland University Hospital, bergen, Norway within the inclusion period (2007- January 2011).

You may qualify if:

  • Solid focal lesions in pancreas or pancreatitis
  • Intramural lesions in esophagus, ventricle or duodenum
  • Lymph nodes or tumour \> 1 cm in mediastinum or retroperitoneum accessible by EUS

You may not qualify if:

  • Cystic pancreatic lesions
  • Patients where the histology or cytology of the lesion in question is known at the time of examination

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Haukeland University Hospital/University of Bergen

Bergen, 5021, Norway

Location

Related Publications (5)

  • Waage JE, Havre RF, Odegaard S, Leh S, Eide GE, Baatrup G. Endorectal elastography in the evaluation of rectal tumours. Colorectal Dis. 2011 Oct;13(10):1130-7. doi: 10.1111/j.1463-1318.2010.02440.x.

    PMID: 21040360BACKGROUND
  • Havre RF, Elde E, Gilja OH, Odegaard S, Eide GE, Matre K, Nesje LB. Freehand real-time elastography: impact of scanning parameters on image quality and in vitro intra- and interobserver validations. Ultrasound Med Biol. 2008 Oct;34(10):1638-50. doi: 10.1016/j.ultrasmedbio.2008.03.009. Epub 2008 Jun 4.

    PMID: 18524458BACKGROUND
  • Saftoiu A, Vilmann P, Gorunescu F, Janssen J, Hocke M, Larsen M, Iglesias-Garcia J, Arcidiacono P, Will U, Giovannini M, Dietrich C, Havre R, Gheorghe C, McKay C, Gheonea DI, Ciurea T; European EUS Elastography Multicentric Study Group. Accuracy of endoscopic ultrasound elastography used for differential diagnosis of focal pancreatic masses: a multicenter study. Endoscopy. 2011 Jul;43(7):596-603. doi: 10.1055/s-0030-1256314. Epub 2011 Mar 24.

    PMID: 21437851BACKGROUND
  • Havre RF, Waage JR, Gilja OH, Odegaard S, Nesje LB. Real-Time Elastography: Strain Ratio Measurements Are Influenced by the Position of the Reference Area. Ultraschall Med. 2012 Dec;33(6):559-568. doi: 10.1055/s-0031-1273247. Epub 2011 Jun 10.

    PMID: 21667433BACKGROUND
  • Saftoiu A, Vilmann P, Gorunescu F, Janssen J, Hocke M, Larsen M, Iglesias-Garcia J, Arcidiacono P, Will U, Giovannini M, Dietrich CF, Havre R, Gheorghe C, McKay C, Gheonea DI, Ciurea T; European EUS Elastography Multicentric Study Group. Efficacy of an artificial neural network-based approach to endoscopic ultrasound elastography in diagnosis of focal pancreatic masses. Clin Gastroenterol Hepatol. 2012 Jan;10(1):84-90.e1. doi: 10.1016/j.cgh.2011.09.014. Epub 2011 Oct 1.

Biospecimen

Retention: SAMPLES WITH DNA

Tissue samples are stored as pathological slides in the diognostic biobank of Dep. of Pathology, Helse Bergen.

MeSH Terms

Conditions

Neoplasm MetastasisLymphatic Metastasis

Condition Hierarchy (Ancestors)

Neoplastic ProcessesNeoplasmsPathologic ProcessesPathological Conditions, Signs and Symptoms

Study Officials

  • Lars Birger Nesje, MD, PhD

    University of Bergen

    STUDY DIRECTOR
  • Roald F. Havre, MD

    University of Bergen

    PRINCIPAL INVESTIGATOR

Study Design

Study Type
observational
Observational Model
CASE ONLY
Time Perspective
PROSPECTIVE
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
MD

Study Record Dates

First Submitted

April 26, 2010

First Posted

May 25, 2011

Study Start

January 1, 2007

Primary Completion

June 1, 2012

Study Completion

July 1, 2012

Last Updated

September 5, 2012

Record last verified: 2012-09

Locations